logo
light
search

RYBOX Holdings List NMFQS:RYBOX

Health | Rydex Funds
$63.99
↓ $-0.42 (-0.65%)
Last Updated: Apr 02, 2026

Rydex Biotechnology Fund Class A (RYBOX) - Health fund with $136.15 Million in assets. The fund allocates 39.42% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.

The largest holding in the fund is AbbVie, Inc. at 8.83% of total assets. This is followed by Amgen, Inc. (5.31%) and Gilead Sciences, Inc. (4.89%).

RYBOX Holdings

Name Weight Owned Change
AbbVie, Inc. 8.83% - -
Amgen, Inc. 5.31% - -
Gilead Sciences, Inc. 4.89% - -
Regeneron Pharmaceuticals, Inc. 3.26% - -
Vertex Pharmaceuticals, Inc. 4.27% - -
Alnylam Pharmaceuticals, Inc. 3.32% - -
Corteva, Inc. 2.81% - -
Biogen, Inc. 2.04% - -
Moderna, Inc. 2.65% - -
AstraZeneca plc 2.04% - -
BeiGene Ltd. 2.40% - -
Insmed, Inc. 2.38% - -
BeOne Medicines Ltd. 2.04% - -

Asset Allocation

Bond 0.00%
Cash 0.19%
Non US Stock 5.28%
Not Classified 0.00%
Other -0.12%
US Stock 94.65%

Market Cap

AverageMarketCap 25725.41%
Giant 2.23%
Large 22.12%
Medium 37.30%
Micro 7.21%
Small 27.91%

Sector Weights

Cash and Equivalents 0.00%
Corporate 0.00%
Derivative 0.00%
Government 0.00%
Municipal 0.00%
Securitized 0.00%
Basic Materials 0.00%
Consumer Cyclical 0.00%
Financial Services 0.00%
Real Estate 0.00%
Consumer Defensive 0.00%
Healthcare 100.00%
Utilities 0.00%
Communication Services 0.00%
Energy 0.00%
Industrials 0.00%
Technology 0.00%

World Regions

Latin America 0.00%
North America 94.72%
Asia Developed 0.00%
Asia Emerging 0.00%
Australasia 0.00%
Japan 0.00%
Africa/Middle East 0.00%
Europe Developed 1.84%
Europe Emerging 0.00%
United Kingdom 3.45%